Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced today that data from a poster highlighting XERMELO® (telotristat ethyl) will be presented at the American Society for Clinical Oncology (ASCO) 2020 Symposium (January 23-25, San Francisco, CA).
Poster Presentation (all times local)
Friday, January 24, 12:00 pm-1:30 pm, 4:30 pm-5:30 pm
Morse, M. et al. Exploring telotristat ethyl's antiproliferative effects in patients with carcinoid syndrome (TELEACE): A real-world observational study (Abstract #618; Poster Board: F21)